CDC Media Relations: Press Release: Texas Joins CDC's Emerging Infections Program Network

ļ»?html> CDC Media Relations: Press Release: Texas Joins CDC's Emerging Infections Program Network


Media Relations Links
ā€?/td>	About Us
ā€?/td>	Media Contact
ā€?/td>	Frequently Asked Questions
ā€?/td>	Media Site Map
CDC News
ā€?/td>	Press Release Library
ā€?/td>	Transcripts
ā€?/td>	MMWR Summaries
ā€?/td>	B-Roll Footage
ā€?/td>	Upcoming Events
Related Links
ā€?/td>	Centers at CDC
ā€?/td>	Data and Statistics
ā€?/td>	Health Topics A-Z
ā€?/td>	Image Library
ā€?/td>	Publications, Software and Other Products
ā€?/td>	Global Health Odyssey

Find your state or local health department

HHS News

National Health Observances



Div. of Media Relations 1600 Clifton Road MS D-14 Atlanta, GA 30333 (404) 639-3286 Fax (404) 639-7394

Press Release

October 10, 2003

Contact: CDC, Division of Media Relations
404-639-3286

Texas Joins CDC's Emerging Infections Program Network

Texas has become the 11th Emerging Infections Program (EIP) site in the United States. The Centers for Disease Control and Prevention (CDC) established EIP sites in 1995 as part of the agencyā€™s strategy to address the ongoing threat of emerging infectious diseases. EIPs are a population-based network of state and local health departments, healthcare providers, and academic institutions. Sites within the network monitor and track infectious diseases, and perform epidemiologic and laboratory research for emerging infectious disease threats.

ā€The EIP sites are key components in strengthening the national public health structure to prevent and control emerging infectious diseases,ā€?said CDC Director Julie L. Gerberding, M.D. ā€Over the past few years, the EIPs have been a national resource for monitoring the impact of a new vaccine against pneumonia in young children, and evaluating and helping to improve guidelines for preventing group B streptococcal disease which is a life-threatening infection in newborns, and measuring the burden of foodborne diseases.ā€?

There are 11 EIP sites: California (San Francisco Bay area), Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, Tennessee, and Texas. The study population for these sites is representative of approximately 36 million people. In fiscal year 2003, EIP sites received nearly $20 million in funding.

Select EIP projects include:

Active Bacterial Core Surveillance (ABCs). Tracking invasive diseases caused by emerging, vaccine-preventable, or drug-resistant pathogens such as Neisseria meningitides and Streptococcus pneumoniae.

Foodborne Disease Active Surveillance Network (FoodNet). Laboratory-based monitoring for foodborne and waterborne diseases.

Surveillance for Infectious Disease Syndromes. Active tracking for SARS and severe pneumonia, encephalitis, chronic and acute liver failure, unexplained rash illnesses, and unexplained deaths and critical illnesses.

For more information about EIP and infectious disease surveillance, visit CDCā€™s National Center for Infectious Diseases (NCID) website: http://www.cy118119.com/ncidod/osr/.

# # #

CDC protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations.

This page last updated October 10, 2003
URL: http://www.cy118119.com/media/pressrel/r031010.htm

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations

¹ś²ś¾«Ę·¾Ć¾Ć¾Ć¾Ć¾ĆŅ»¼¶Ć«Ę¬